Breast cancer ranks as one of the most frequently diagnosed malignant neoplasm in women embracing multiple genomic alterations that influence tumor growth, progression, and metastasis. Despite significant advancements in systemic adjuvant chemotherapy for breast cancer, manifestations of distant metastasis raise significant clinical problems with worst prognosis. Therefore, defining molecular events underlying metastasis alongside well defined strategic abrogation of these molecular events is crucial for improving patient survival and better clinical management. The classic "seed and soil" hypothesis of tumor metastasis has been redefined in light of emerging evidence revealing chemokine [CXCL12 (SDF-1α)] and its cognate receptor (CXCR4) orchestrating signaling events that guide chemotaxis of tumor cells to site of metastasis. CXCR4 is a transmembrane G proteincoupled receptor reportedly overexpressed in primary and metastatic breast tumors compared to normal breast tissue, and its chemokine ligand (SDF-1α) presents peak expression in common metastatic sites. CXCR4-SDF-1α signaling has earned considerable attention underscoring its role in cancer metastasis including activation of focal clusters of integrin and adhesion kinase (Rho/ROCK) and multiple signaling entities (Cdc42, PI3K-Akt, p38 MAPK) that allow tumor cells to attain a migratory phenotype. Hypoxia, vascular endothelial growth factor (VEGF), transcription factor NF-κB, and estrogen receptor status upregulates CXCR4 expression in tumor microenvironment. A growing body of evidence suggests that natural chemo-dietary agents hold prospect targeting CXCR4-SDF-1α axis to prevent metastasis of breast cancer. This chapter presents a succinct overview about CXCR4 receptor signaling in breast cancer and related mechano-transductive pathways, microenvironmental cues, and current status and knowledge regarding efficacy of bioactive natural products on metastasis and homing of malignant tumor cells.